HomeAI · summaries
Storia in 4 fonti
Maharashtra FDA cancels Cipla Pune unit’s sale licence; company contests order
Cipla is contesting a Maharashtra FDA order over packaging, storage, labelling and recall irregularities at its Pune C&F unit involving Reactin Plus Tablets.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindu.com
FDA cancels drug sale licences of Cipla Pharma & Life Sciences' Pune Carry and Forwarding unit
FDA cancels Cipla Pharma's drug sale licenses due to serious storage and handling irregularities at its Pune unit.
- ·
economictimes.indiatimes.com
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations
Maharashtra FDA cancelled Cipla's Pune unit drug sale licences. Serious irregularities in storage and recall procedures were cited by the regulator. The company failed to fully…
